MedTrace Logo

Increasing Optimal Use of HPV Vaccination in Primary Care

NCT04180462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-03-25

Study results available
· View outcomes & findings →

Summary

Washington University will evaluate the effectiveness of a multi-component implementation strategy to increase use of HPV vaccine in primary care practices.

Conditions

  • Human Papillomavirus Vaccines

Interventions

OTHER

Practice Facilitation

Practice facilitation to support quality improvement methods to effect practice change to develop a sustainable HPV vaccine delivery system.

OTHER

Education

An educational video to increase the provider's knowledge about guideline recommendations and patient and practice benefits of vaccination by age 13.

OTHER

Audit and Feedback

Audit and feedback of vaccine coverage to increase motivation to engage in practice change.

OTHER

Communication Strategy

A communication strategy to improve the provider's communication skills and their self-efficacy to address parental hesitation.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Allison King, M.D., Ph.D., MPH · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-07
Primary Completion
2023-02-14
Completion
2024-04-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04180462 on ClinicalTrials.gov